Danaher Corporation $DHR Stake Lessened by Violich Capital Management Inc.

Key Points

• Violich Capital Management Inc. reduced its stake in Danaher Corporation by 11.2%, now holding 32,599 shares valued at approximately $6.44 million.
• Analysts are optimistic about Danaher, with a consensus rating of "Moderate Buy" and a target price averaging $245.00.
• Danaher announced a quarterly dividend of $0.32 per share, representing an annual yield of 0.6%.

Violich Capital Management Inc. lowered its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 11.2% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,599 shares of the conglomerate's stock after selling 4,100 shares during the period. Danaher makes up 0.9% of Violich Capital Management Inc.'s portfolio, making the stock its 26th biggest position. Violich Capital Management Inc.'s holdings in Danaher were worth $6,440,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. GHP Investment Advisors Inc. lifted its holdings in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC raised its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher during the first quarter worth $31,000. Red Tortoise LLC raised its holdings in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Costello Asset Management INC purchased a new stake in shares of Danaher during the first quarter worth $41,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Robert W. Baird increased their price objective on Danaher from $229.00 to $236.00 and gave the stock an "outperform" rating in a report on Wednesday. Bank of America cut their price objective on Danaher from $230.00 to $220.00 and set a "buy" rating for the company in a report on Monday, September 22nd. Barclays reiterated an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Weiss Ratings restated a "hold (c-)" rating on shares of Danaher in a report on Wednesday, October 8th. Finally, Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $245.00.

Danaher Trading Down 0.8%

Shares of NYSE:DHR opened at $209.14 on Friday. The company has a market cap of $149.76 billion, a P/E ratio of 44.50, a P/E/G ratio of 2.98 and a beta of 0.77. The stock's 50-day moving average is $201.60 and its 200-day moving average is $197.24. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $275.51. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm's revenue was up 3.4% compared to the same quarter last year. During the same period last year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's dividend payout ratio (DPR) is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.